Tianyikang Biotechnology

Tianyikang Biotechnology focuses on medical research and the development and application of next-generation cell immunotherapy products.

ActiveBioTechMedicalPharmaceutical

Updated: Feb 17, 2026 ·

Recent News & Mentions

Tianyikang Biotechnology most recently raised Seed in February 2026.

Total Raised

N/A

Valuation

N/A

Date	Round	Lead Investors	Other Investors
Feb 9, 2026	Seed		Guangzhou Guofa Venture Capital, Hony Capital, Mpow Health Fund

Total Raised

N/A

Valuation

N/A

Who are Tianyikang Biotechnology's investors?

Tianyikang Biotechnology's investors include Guangzhou Guofa Venture Capital, Hony Capital, Mpow Health Fund.